MLECW
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/E, PEG, Graham Number
- P/B ratio is very low
- No earnings to support valuation
- No Graham Number available
Ref Growth rates
- No evidence of revenue growth
- No forward guidance
Ref Historical trends
- Long term 5Y change is slightly positive
- Recent 1-month decline of 13.8%
Ref Altman Z-Score, Piotroski F-Score
- Piotroski F-Score 1/9 indicates extreme weakness
Ref Yield, Payout
- No dividend history or capacity
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for MLECW and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
MLECW
Moolec Science SA
Primary
|
+5.9% | +5.9% | +5.9% | +5.9% | -13.8% | -13.8% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2024
Past News Coverage
Recent headlines mentioning MLECW from our newsroom.